Neuronox 100 Units

What is it?

Neuronox 100 Units is a botulinum toxin type A injectable solution developed by MedyTox Inc. in South Korea and distributed globally. It is widely recognized as a safe and effective alternative to well-known brands such as Botox® (Ona-BoNT/A), offering comparable efficacy at a more competitive price. Approved and registered in more than 30 countries, including Korea, Brazil, India, Hong Kong, Ukraine, Thailand, and Mexico, Neuronox is also under review in numerous additional markets, making it a trusted product in both aesthetic and therapeutic practices. This high-quality formulation is designed to temporarily block nerve impulses to targeted muscles, reducing their activity and thereby smoothing dynamic wrinkles, restoring natural facial harmony, and treating a range of medical conditions such as hyperhidrosis and blepharospasm.

Key Benefits

Clinically proven efficacy in reducing moderate to severe facial wrinkles.
A cost-effective alternative to leading botulinum toxin brands without compromising quality.
Registered and widely used across multiple continents, ensuring international trust and recognition.
Rapid onset of visible results, typically within 2–3 days of treatment.
High level of patient safety and tolerance, supported by extensive clinical studies.
Broad range of applications, from aesthetic wrinkle reduction to therapeutic muscle and sweat gland management.

Effects

Significant smoothing of glabellar (frown) lines, forehead lines, and crow’s feet.
Correction of lip contour and reduction of perioral wrinkles caused by repetitive muscle movement.
Improvement in neck appearance, including the reduction of “Venus rings.”
Relief of eyelid spasms (blepharospasm) and management of cervical dystonia.
Effective reduction of hyperhidrosis (excessive sweating), particularly in the underarms, palms, and feet.
Enhanced facial symmetry and youthful skin appearance through precise muscle relaxation.

Duration

Results typically last between 6 and 8 months depending on individual factors, treatment area, and dosage.
Maintenance treatments are usually recommended 2–3 times annually to sustain results.

Composition & Packaging

Main Ingredients: Botulinum toxin type A (strain CBFC26), human serum albumin (~0.25 mg), sodium chloride (~0.45 mg).
Form: Lyophilized white powder requiring reconstitution with saline before injection.
Packing Unit: 1 vial containing 100 units.
Storage: Must be kept refrigerated at 2–8°C.
Manufacturer: MedyTox Inc., South Korea.

Contraindications & Precautions

Contraindicated in individuals with hypersensitivity to botulinum toxin or any excipients.
Should not be used in patients with neuromuscular junction disorders (e.g., myasthenia gravis, Lambert-Eaton syndrome).
Not recommended during pregnancy or breastfeeding without strict medical guidance.
Common, temporary side effects may include localized pain, swelling, bruising, headache, or mild eyelid drooping.
Rare but serious adverse effects can involve generalized muscle weakness, vision problems, or breathing difficulties if the toxin spreads beyond the injection site.

Neuronox 100 Units provides reliable, natural-looking results by combining advanced biotechnology, international clinical approval, and wide-ranging applications, making it a versatile choice for both cosmetic professionals and medical practitioners.